KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Tenet Healthcare (THC) Income towards Parent Company (2016 - 2025)

Tenet Healthcare's Income towards Parent Company history spans 17 years, with the latest figure at $816.0 million for Q4 2025.

  • For Q4 2025, Income towards Parent Company rose 42.66% year-over-year to $816.0 million; the TTM value through Dec 2025 reached $2.7 billion, down 33.17%, while the annual FY2025 figure was $2.4 billion, 41.76% down from the prior year.
  • Income towards Parent Company for Q4 2025 was $816.0 million at Tenet Healthcare, up from $756.0 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $2.3 billion in Q1 2024 and bottomed at -$1.0 million in Q2 2021.
  • The 5-year median for Income towards Parent Company is $466.5 million (2023), against an average of $529.2 million.
  • The largest annual shift saw Income towards Parent Company crashed 99.55% in 2022 before it surged 29500.0% in 2023.
  • A 5-year view of Income towards Parent Company shows it stood at $420.0 million in 2021, then crashed by 99.76% to $1.0 million in 2022, then soared by 45500.0% to $456.0 million in 2023, then grew by 25.44% to $572.0 million in 2024, then surged by 42.66% to $816.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Income towards Parent Company are $816.0 million (Q4 2025), $756.0 million (Q3 2025), and $522.0 million (Q2 2025).